Actinium Pharmaceuticals, Inc.

Rockefeller Capital Management L.P. ATNM

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/13/2026

4,000

Value ($000)

Weight

0.0%

2020 Q3 - 2026 Q2 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/13/2026	4	0.0%	4,000	6/30/2026
2026 Q1	5/14/2026	4	0.0%	4,000	3/31/2026
2025 Q4	3/16/2026	5	0.0%	4,000	12/31/2025
2025 Q3	11/14/2025	7	0.0%	4,500	9/30/2025
2023 Q2	8/14/2023	109	0.0%	14,733	6/30/2023
2023 Q1	5/16/2023	150	0.0%	15,923	3/31/2023
2022 Q4	3/6/2023	160	0.0%	15,081	12/31/2022
2022 Q3	11/2/2022	105	0.0%	14,331	9/30/2022
2022 Q2	8/12/2022	61	0.0%	12,881	6/30/2022
2022 Q1	5/13/2022	60	0.0%	11,881	3/31/2022
2021 Q4	2/14/2022	50	0.0%	8,381	12/31/2021
2021 Q3	11/12/2021	74	0.0%	8,381	9/30/2021
2021 Q2	8/10/2021	54	0.0%	6,881	6/30/2021
2021 Q1	5/11/2021	52	0.0%	6,881	3/31/2021
2020 Q4	2/12/2021	29	0.0%	3,780	12/31/2020
2020 Q3	11/13/2020	20	0.0%	2,103	9/30/2020